녹십자웰빙

234690KOSDAQ

70.8 / 100

Reference Date: 2026-09-08

Financial Score24.5 / 40

News Sentiment21.3 / 25

Momentum15.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health and ROE is above the industry average is also solid. Surged 15.2% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

LS Wellbeing operates in professional pharmaceuticals, clinic-based health functional foods, and medical devices/cosmetics (aesthetics), achieving a 6.1% revenue growth to 127.9 billion KRW in 2024. Key products include injectable nutritional solutions like Lainex Injection, health functional food brand Dr.PNT, and medical devices such as HA fillers and skin boosters, with active exports to the Chinese market.

Number of Employees

330people

Average Salary

71.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

18.00Industry Average 15.003.0Point

Higher than industry avg (caution)

PBR

1.62Industry Average 1.202.5Point

Higher than industry avg (caution)

ROE

9.20Industry Average 8.004.0Point

In line with industry avg

Debt Ratio

30.62Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20258.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲17.0% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲28.7% (2-year basis)

ROE Trend

3.0 / 4

Avg ROE 7.7% (improving, 3yr)

Detailed News Sentiment

15 totalPositive 15Neutral 0Negative 0Average Sentiment Score 85

Positive
피부 노화, 콜라겐 부족보다 '이것'이 더 문제?필리핀도 주목한 한국....
GC녹십자웰빙의 '지셀르 리본느'가 필리핀에서 성공적인 심포지엄을 통해 동남아시아 미용시장 진출을 가속화하고 있다.
Positive
GC녹십자웰빙 파트너사, 지방분해 신약 中 임상 3상 성공
GC녹십자웰빙 파트너사의 지방분해 신약이 중국 임상 3상에서 성공적으로 완료되어 상업화 가능성이 높아졌다.
Positive
GC녹십자웰빙, ECM 스킨부스터 ‘리본느’ 필리핀 출시
GC녹십자웰빙의 새로운 스킨부스터 '리본느' 필리핀 출시로 동남아 시장 진출 확대 기대.

Detailed Momentum

52-week position3.0Point

52w lower range (36%)

Current 10,150Won52-week high 15,10052-week low 7,250

1-month return6.0Point

1m +15.21% (strong rise)

Volume trend6.0Point

Volume surge

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-14